▶ 調査レポート

世界のデスモイド腫瘍治療市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Desmoid Tumor Treatment Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のデスモイド腫瘍治療市場規模・現状・予測(2021年-2027年) / Global Desmoid Tumor Treatment Market Size, Status and Forecast 2021-2027 / QFJ1-4115資料のイメージです。• レポートコード:QFJ1-4115
• 出版社/出版日:QYResearch / 2021年6月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査レポートでは、デスモイド腫瘍治療の世界市場(2016年~2027年)を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模(医療処置、投薬)、用途別市場規模(病院、診療所、ASC、在宅医療、学術研究センター、私立研究所)、主要地域別市場規模(北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、企業情報などをまとめております。
・市場概要
・デスモイド腫瘍治療の市場動向
・企業の競争状況、市場シェア
・デスモイド腫瘍治療の種類別市場規模と予測2016-2027(医療処置、投薬)
・デスモイド腫瘍治療の用途別市場規模と予測2016-2027(病院、診療所、ASC、在宅医療、学術研究センター、私立研究所)
・デスモイド腫瘍治療の北米市場規模2016-2027(アメリカ、カナダ)
・デスモイド腫瘍治療の欧州市場規模2016-2027(ドイツ、フランス、イギリス等)
・デスモイド腫瘍治療のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・デスモイド腫瘍治療の中南米市場規模2016-2027(メキシコ、ブラジル)
・デスモイド腫瘍治療の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Novartis AG、Amgen Inc、Abbott Laboratories、AbbVie Inc、Bayer AG、Stryker Corporation、Beckman Coulter Inc、Debiopharm Group、F. Hoffmann-La Roche Ltd.)
・結論

Desmoid tumor is a rare condition where tumor develops in the fibrous or connective tissue present in the body. Most observations has led to a conclusion that desmoid tumors are more visible in the t tendons and ligaments, usually in the legs, midsection and arms, and also desmoid tumor can be found in the sections of the head and neck. There can be a wide range of clinical symptoms associated with desmoid tumor treatment. Symptoms like rupture of intestines, severe pain, bloating, compression of the kidneys or ureters or rectal bleeding. Desmoid tumor treatment starts with proper diagnosis methods which include ultrasound, MRI and/or CT scans. First line desmoid tumor treatment include real time observation of the patent collecting all range of behaviors. Desmoid tumor treatment include medical procedures to kill the tumor or surgically remove the tumor, the desmoid tumor treatment also include medication to support the procedure.

Market Analysis and Insights: Global Desmoid Tumor Treatment Market
The global Desmoid Tumor Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Desmoid Tumor Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Desmoid Tumor Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Desmoid Tumor Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Desmoid Tumor Treatment market.

Global Desmoid Tumor Treatment Scope and Market Size
Desmoid Tumor Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Desmoid Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Medical Procedure
Medication

Segment by Application
Hospital
Clinic
ASCs
Home Care
Academic Research Center
Private Laboratory

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Novartis AG
Amgen Inc
Abbott Laboratories
AbbVie Inc
Bayer AG
Stryker Corporation
Beckman Coulter Inc
Debiopharm Group
F. Hoffmann-La Roche Ltd.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Desmoid Tumor Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Medical Procedure
1.2.3 Medication
1.3 Market by Application
1.3.1 Global Desmoid Tumor Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 ASCs
1.3.5 Home Care
1.3.6 Academic Research Center
1.3.7 Private Laboratory
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Desmoid Tumor Treatment Market Perspective (2016-2027)
2.2 Desmoid Tumor Treatment Growth Trends by Regions
2.2.1 Desmoid Tumor Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Desmoid Tumor Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Desmoid Tumor Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Desmoid Tumor Treatment Industry Dynamic
2.3.1 Desmoid Tumor Treatment Market Trends
2.3.2 Desmoid Tumor Treatment Market Drivers
2.3.3 Desmoid Tumor Treatment Market Challenges
2.3.4 Desmoid Tumor Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Desmoid Tumor Treatment Players by Revenue
3.1.1 Global Top Desmoid Tumor Treatment Players by Revenue (2016-2021)
3.1.2 Global Desmoid Tumor Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Desmoid Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Desmoid Tumor Treatment Revenue
3.4 Global Desmoid Tumor Treatment Market Concentration Ratio
3.4.1 Global Desmoid Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Desmoid Tumor Treatment Revenue in 2020
3.5 Desmoid Tumor Treatment Key Players Head office and Area Served
3.6 Key Players Desmoid Tumor Treatment Product Solution and Service
3.7 Date of Enter into Desmoid Tumor Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Desmoid Tumor Treatment Breakdown Data by Type
4.1 Global Desmoid Tumor Treatment Historic Market Size by Type (2016-2021)
4.2 Global Desmoid Tumor Treatment Forecasted Market Size by Type (2022-2027)

5 Desmoid Tumor Treatment Breakdown Data by Application
5.1 Global Desmoid Tumor Treatment Historic Market Size by Application (2016-2021)
5.2 Global Desmoid Tumor Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Desmoid Tumor Treatment Market Size (2016-2027)
6.2 North America Desmoid Tumor Treatment Market Size by Type
6.2.1 North America Desmoid Tumor Treatment Market Size by Type (2016-2021)
6.2.2 North America Desmoid Tumor Treatment Market Size by Type (2022-2027)
6.2.3 North America Desmoid Tumor Treatment Market Size by Type (2016-2027)
6.3 North America Desmoid Tumor Treatment Market Size by Application
6.3.1 North America Desmoid Tumor Treatment Market Size by Application (2016-2021)
6.3.2 North America Desmoid Tumor Treatment Market Size by Application (2022-2027)
6.3.3 North America Desmoid Tumor Treatment Market Size by Application (2016-2027)
6.4 North America Desmoid Tumor Treatment Market Size by Country
6.4.1 North America Desmoid Tumor Treatment Market Size by Country (2016-2021)
6.4.2 North America Desmoid Tumor Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Desmoid Tumor Treatment Market Size (2016-2027)
7.2 Europe Desmoid Tumor Treatment Market Size by Type
7.2.1 Europe Desmoid Tumor Treatment Market Size by Type (2016-2021)
7.2.2 Europe Desmoid Tumor Treatment Market Size by Type (2022-2027)
7.2.3 Europe Desmoid Tumor Treatment Market Size by Type (2016-2027)
7.3 Europe Desmoid Tumor Treatment Market Size by Application
7.3.1 Europe Desmoid Tumor Treatment Market Size by Application (2016-2021)
7.3.2 Europe Desmoid Tumor Treatment Market Size by Application (2022-2027)
7.3.3 Europe Desmoid Tumor Treatment Market Size by Application (2016-2027)
7.4 Europe Desmoid Tumor Treatment Market Size by Country
7.4.1 Europe Desmoid Tumor Treatment Market Size by Country (2016-2021)
7.4.2 Europe Desmoid Tumor Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Desmoid Tumor Treatment Market Size (2016-2027)
8.2 Asia-Pacific Desmoid Tumor Treatment Market Size by Type
8.2.1 Asia-Pacific Desmoid Tumor Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Desmoid Tumor Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Desmoid Tumor Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Desmoid Tumor Treatment Market Size by Application
8.3.1 Asia-Pacific Desmoid Tumor Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Desmoid Tumor Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Desmoid Tumor Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Desmoid Tumor Treatment Market Size by Region
8.4.1 Asia-Pacific Desmoid Tumor Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Desmoid Tumor Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Desmoid Tumor Treatment Market Size (2016-2027)
9.2 Latin America Desmoid Tumor Treatment Market Size by Type
9.2.1 Latin America Desmoid Tumor Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Desmoid Tumor Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Desmoid Tumor Treatment Market Size by Type (2016-2027)
9.3 Latin America Desmoid Tumor Treatment Market Size by Application
9.3.1 Latin America Desmoid Tumor Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Desmoid Tumor Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Desmoid Tumor Treatment Market Size by Application (2016-2027)
9.4 Latin America Desmoid Tumor Treatment Market Size by Country
9.4.1 Latin America Desmoid Tumor Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Desmoid Tumor Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Desmoid Tumor Treatment Market Size (2016-2027)
10.2 Middle East & Africa Desmoid Tumor Treatment Market Size by Type
10.2.1 Middle East & Africa Desmoid Tumor Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Desmoid Tumor Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Desmoid Tumor Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Desmoid Tumor Treatment Market Size by Application
10.3.1 Middle East & Africa Desmoid Tumor Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Desmoid Tumor Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Desmoid Tumor Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Desmoid Tumor Treatment Market Size by Country
10.4.1 Middle East & Africa Desmoid Tumor Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Desmoid Tumor Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Desmoid Tumor Treatment Introduction
11.1.4 Novartis AG Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.1.5 Novartis AG Recent Development
11.2 Amgen Inc
11.2.1 Amgen Inc Company Details
11.2.2 Amgen Inc Business Overview
11.2.3 Amgen Inc Desmoid Tumor Treatment Introduction
11.2.4 Amgen Inc Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.2.5 Amgen Inc Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Desmoid Tumor Treatment Introduction
11.3.4 Abbott Laboratories Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.3.5 Abbott Laboratories Recent Development
11.4 AbbVie Inc
11.4.1 AbbVie Inc Company Details
11.4.2 AbbVie Inc Business Overview
11.4.3 AbbVie Inc Desmoid Tumor Treatment Introduction
11.4.4 AbbVie Inc Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.4.5 AbbVie Inc Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Details
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Desmoid Tumor Treatment Introduction
11.5.4 Bayer AG Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.5.5 Bayer AG Recent Development
11.6 Stryker Corporation
11.6.1 Stryker Corporation Company Details
11.6.2 Stryker Corporation Business Overview
11.6.3 Stryker Corporation Desmoid Tumor Treatment Introduction
11.6.4 Stryker Corporation Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.6.5 Stryker Corporation Recent Development
11.7 Beckman Coulter Inc
11.7.1 Beckman Coulter Inc Company Details
11.7.2 Beckman Coulter Inc Business Overview
11.7.3 Beckman Coulter Inc Desmoid Tumor Treatment Introduction
11.7.4 Beckman Coulter Inc Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.7.5 Beckman Coulter Inc Recent Development
11.8 Debiopharm Group
11.8.1 Debiopharm Group Company Details
11.8.2 Debiopharm Group Business Overview
11.8.3 Debiopharm Group Desmoid Tumor Treatment Introduction
11.8.4 Debiopharm Group Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.8.5 Debiopharm Group Recent Development
11.9 F. Hoffmann-La Roche Ltd.
11.9.1 F. Hoffmann-La Roche Ltd. Company Details
11.9.2 F. Hoffmann-La Roche Ltd. Business Overview
11.9.3 F. Hoffmann-La Roche Ltd. Desmoid Tumor Treatment Introduction
11.9.4 F. Hoffmann-La Roche Ltd. Revenue in Desmoid Tumor Treatment Business (2016-2021)
11.9.5 F. Hoffmann-La Roche Ltd. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Desmoid Tumor Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Medical Procedure
Table 3. Key Players of Medication
Table 4. Global Desmoid Tumor Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Desmoid Tumor Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Desmoid Tumor Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Desmoid Tumor Treatment Market Share by Regions (2016-2021)
Table 8. Global Desmoid Tumor Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Desmoid Tumor Treatment Market Share by Regions (2022-2027)
Table 10. Desmoid Tumor Treatment Market Trends
Table 11. Desmoid Tumor Treatment Market Drivers
Table 12. Desmoid Tumor Treatment Market Challenges
Table 13. Desmoid Tumor Treatment Market Restraints
Table 14. Global Desmoid Tumor Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Desmoid Tumor Treatment Market Share by Players (2016-2021)
Table 16. Global Top Desmoid Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Desmoid Tumor Treatment as of 2020)
Table 17. Ranking of Global Top Desmoid Tumor Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Desmoid Tumor Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Desmoid Tumor Treatment Product Solution and Service
Table 21. Date of Enter into Desmoid Tumor Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Desmoid Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Desmoid Tumor Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Desmoid Tumor Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Desmoid Tumor Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Desmoid Tumor Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Desmoid Tumor Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Desmoid Tumor Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Desmoid Tumor Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Desmoid Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Desmoid Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Desmoid Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Desmoid Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Desmoid Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Desmoid Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Desmoid Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Desmoid Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Desmoid Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Desmoid Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Desmoid Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Desmoid Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Desmoid Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Desmoid Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Desmoid Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Desmoid Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Desmoid Tumor Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Desmoid Tumor Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Desmoid Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Desmoid Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Desmoid Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Desmoid Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Desmoid Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Desmoid Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Desmoid Tumor Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Desmoid Tumor Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Desmoid Tumor Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Desmoid Tumor Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Desmoid Tumor Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Desmoid Tumor Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Novartis AG Company Details
Table 62. Novartis AG Business Overview
Table 63. Novartis AG Desmoid Tumor Treatment Product
Table 64. Novartis AG Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 65. Novartis AG Recent Development
Table 66. Amgen Inc Company Details
Table 67. Amgen Inc Business Overview
Table 68. Amgen Inc Desmoid Tumor Treatment Product
Table 69. Amgen Inc Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 70. Amgen Inc Recent Development
Table 71. Abbott Laboratories Company Details
Table 72. Abbott Laboratories Business Overview
Table 73. Abbott Laboratories Desmoid Tumor Treatment Product
Table 74. Abbott Laboratories Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 75. Abbott Laboratories Recent Development
Table 76. AbbVie Inc Company Details
Table 77. AbbVie Inc Business Overview
Table 78. AbbVie Inc Desmoid Tumor Treatment Product
Table 79. AbbVie Inc Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 80. AbbVie Inc Recent Development
Table 81. Bayer AG Company Details
Table 82. Bayer AG Business Overview
Table 83. Bayer AG Desmoid Tumor Treatment Product
Table 84. Bayer AG Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 85. Bayer AG Recent Development
Table 86. Stryker Corporation Company Details
Table 87. Stryker Corporation Business Overview
Table 88. Stryker Corporation Desmoid Tumor Treatment Product
Table 89. Stryker Corporation Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 90. Stryker Corporation Recent Development
Table 91. Beckman Coulter Inc Company Details
Table 92. Beckman Coulter Inc Business Overview
Table 93. Beckman Coulter Inc Desmoid Tumor Treatment Product
Table 94. Beckman Coulter Inc Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 95. Beckman Coulter Inc Recent Development
Table 96. Debiopharm Group Company Details
Table 97. Debiopharm Group Business Overview
Table 98. Debiopharm Group Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 99. Debiopharm Group Recent Development
Table 100. F. Hoffmann-La Roche Ltd. Company Details
Table 101. F. Hoffmann-La Roche Ltd. Business Overview
Table 102. F. Hoffmann-La Roche Ltd. Desmoid Tumor Treatment Product
Table 103. F. Hoffmann-La Roche Ltd. Revenue in Desmoid Tumor Treatment Business (2016-2021) & (US$ Million)
Table 104. F. Hoffmann-La Roche Ltd. Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Desmoid Tumor Treatment Market Share by Type: 2020 VS 2027
Figure 2. Medical Procedure Features
Figure 3. Medication Features
Figure 4. Global Desmoid Tumor Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. ASCs Case Studies
Figure 8. Home Care Case Studies
Figure 9. Academic Research Center Case Studies
Figure 10. Private Laboratory Case Studies
Figure 11. Desmoid Tumor Treatment Report Years Considered
Figure 12. Global Desmoid Tumor Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Desmoid Tumor Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Desmoid Tumor Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Desmoid Tumor Treatment Market Share by Regions (2022-2027)
Figure 16. Global Desmoid Tumor Treatment Market Share by Players in 2020
Figure 17. Global Top Desmoid Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Desmoid Tumor Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Desmoid Tumor Treatment Revenue in 2020
Figure 19. Global Desmoid Tumor Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Desmoid Tumor Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Desmoid Tumor Treatment Market Share by Type (2016-2027)
Figure 23. North America Desmoid Tumor Treatment Market Share by Application (2016-2027)
Figure 24. North America Desmoid Tumor Treatment Market Share by Country (2016-2027)
Figure 25. United States Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Desmoid Tumor Treatment Market Share by Type (2016-2027)
Figure 29. Europe Desmoid Tumor Treatment Market Share by Application (2016-2027)
Figure 30. Europe Desmoid Tumor Treatment Market Share by Country (2016-2027)
Figure 31. Germany Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Desmoid Tumor Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Desmoid Tumor Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Desmoid Tumor Treatment Market Share by Region (2016-2027)
Figure 41. China Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Desmoid Tumor Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Desmoid Tumor Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Desmoid Tumor Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Desmoid Tumor Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Desmoid Tumor Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Desmoid Tumor Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Desmoid Tumor Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Novartis AG Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 61. Amgen Inc Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 62. Abbott Laboratories Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 63. AbbVie Inc Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 64. Bayer AG Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 65. Stryker Corporation Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 66. Beckman Coulter Inc Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 67. Debiopharm Group Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 68. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Desmoid Tumor Treatment Business (2016-2021)
Figure 69. Bottom-up and Top-down Approaches for This Report
Figure 70. Data Triangulation
Figure 71. Key Executives Interviewed